Detke Michael J.

CIK 00017707861 companySOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001770786

Recent Transactions

26 trades

Award
Quince Therapeutics, Inc.$QNCX
Common Stock
2022-03-03+140,000→ 140,000 total
Award
Quince Therapeutics, Inc.$QNCX
Stock Option (right to buy)
2022-01-03+125,000→ 125,000 total
Exercise/Conversion
Quince Therapeutics, Inc.$QNCX
Common Stock
2021-08-10$2.23/sh+10,000→ 10,000 total
Exercise/Conversion
Quince Therapeutics, Inc.$QNCX
Stock Option (right to buy)
2021-08-10−10,000→ 92,352 total
Sale
Quince Therapeutics, Inc.$QNCX
Common Stock
2021-08-10$100.00/sh−10,000→ 0 total
Sale
Quince Therapeutics, Inc.$QNCX
Common Stock
2021-07-07$54.37/sh−1,648→ 11,818 total
Exercise/Conversion
Quince Therapeutics, Inc.$QNCX
Stock Option (right to buy)
2021-07-07−17,400→ 102,352 total
Sale
Quince Therapeutics, Inc.$QNCX
Common Stock
2021-07-07$56.27/sh−6,942→ 523 total
Sale
Quince Therapeutics, Inc.$QNCX
Common Stock
2021-07-07$53.24/sh−3,934→ 13,466 total
Sale
Quince Therapeutics, Inc.$QNCX
Common Stock
2021-07-07$55.38/sh−4,353→ 7,465 total
Sale
Quince Therapeutics, Inc.$QNCX
Common Stock
2021-07-07$56.99/sh−523→ 0 total
Exercise/Conversion
Quince Therapeutics, Inc.$QNCX
Common Stock
2021-07-07$2.23/sh+17,400→ 17,400 total
Sale
Quince Therapeutics, Inc.$QNCX
Common Stock
2021-07-06$53.43/sh−32,313→ 8,548 total
Exercise/Conversion
Quince Therapeutics, Inc.$QNCX
Common Stock
2021-07-06$2.23/sh+12,600→ 40,861 total
Sale
Quince Therapeutics, Inc.$QNCX
Common Stock
2021-07-06$53.91/sh−8,260→ 288 total
Sale
Quince Therapeutics, Inc.$QNCX
Common Stock
2021-07-06$55.01/sh−288→ 0 total
Exercise/Conversion
Quince Therapeutics, Inc.$QNCX
Stock Option (right to buy)
2021-07-06−12,600→ 119,752 total
Award
Quince Therapeutics, Inc.$QNCX
Stock Option (Right to Buy)
2020-12-11+100,000→ 100,000 total
Award
Quince Therapeutics, Inc.$QNCX
Stock Option (Right to Buy)
2020-12-11+100,000→ 100,000 total
Exercise/Conversion
Quince Therapeutics, Inc.$QNCX
Common Stock
2020-05-27$6.91/sh+5,515→ 28,261 total
Exercise/Conversion
Quince Therapeutics, Inc.$QNCX
Stock Option (Right to Buy)
2020-05-27−5,515→ 104,091 total
Exercise/Conversion
Quince Therapeutics, Inc.$QNCX
Common Stock
2020-04-02$6.91/sh+5,515→ 22,746 total
Exercise/Conversion
Quince Therapeutics, Inc.$QNCX
Stock Option (Right to Buy)
2020-04-02−5,515→ 109,606 total
Exercise/Conversion
Quince Therapeutics, Inc.$QNCX
Common Stock
2020-02-07$6.91/sh+17,231→ 17,231 total
Exercise/Conversion
Quince Therapeutics, Inc.$QNCX
Stock Option (Right to Buy)
2020-02-07−17,231→ 115,121 total
Award
Quince Therapeutics, Inc.$QNCX
Stock Option (Right to Buy)
2020-02-06+100,000→ 100,000 total

Companies

Quince Therapeutics, Inc.
Chief Medical Officer
$QNCX

Recent Filings

Address

C/O CORTEXYME, INC. 269 EAST GRAND AVE.

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov